|
Recent Developments |
|
19-OCT-10
Alembic, the pharmaceutical major, today posted 72% growth in consolidated net profit at Rs 267.1 million for the quarter ended September 2010 against Rs 155.4 million posted in corresponding quarter last fiscal.
30-JUL-10
Alembic is slated to announce its Q1FY`11 Alembic is slated to announce its Q1FY`11 Alembic is slated to announce its Q1FY`11
20-JUL-10
At 12.49., the Sensex was trading up 47.39 points or 0.26% at 17,975.81 with ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 5882.89 | 6960.70 | 6963.08 | | Other Income | 260.57 | 278.20 | 250.08 | | Total Income | 6143.47 | 7238.90 | 7213.16 | | Cost of goods sold | 4402.27 | 5375.10 | 5370.07 | | OPBDIT | 1741.19 | 1863.80 | 1843.09 | | PAT | 1222.43 | 1326.91 | 1487.46 | | Gross Block | - | - | - | | Equity capital | 182.37 | 182.92 | 184.57 | | EPS (Rs.) | - | 7.22 | 7.99 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 10.53 - 15.36 | 9.89 - 14.71 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 28.3 | 25.7 | 25.6 | | Net margin (% of OI) | 19.9 | 18.3 | 20.6 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
